Arcadia Biosciences Inc (RKDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,003 | -1,859 | 2,599 | -7,038 | -2,974 |
| Depreciation Amortization | 83 | 76 | 48 | 608 | 504 |
| Accounts receivable | -241 | -417 | -193 | -762 | -445 |
| Other Working Capital | -530 | -1,360 | -701 | -1,446 | -975 |
| Other Operating Activity | -2,187 | -61 | -3,341 | -989 | -3,528 |
| Operating Cash Flow | $-3,878 | $-3,621 | $-1,588 | $-9,627 | $-7,418 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | 318 | 326 |
| Net Acquisitions | N/A | N/A | N/A | 2,000 | 2,000 |
| Sale Of Investment | N/A | N/A | N/A | 5,024 | 2,501 |
| Other Investing Activity | 750 | 750 | 500 | 0 | 0 |
| Investing Cash Flow | $750 | $750 | $500 | $7,342 | $4,827 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 6 | 5 | 5 | 9 | 9 |
| Financing Cash Flow | $6 | $5 | $5 | $9 | $9 |
| Beginning Cash Position | 4,242 | 4,242 | 4,242 | 6,518 | 6,518 |
| End Cash Position | 1,120 | 1,376 | 3,159 | 4,242 | 3,936 |
| Net Cash Flow | $-3,122 | $-2,866 | $-1,083 | $-2,276 | $-2,582 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,878 | -3,621 | -1,588 | -9,627 | -7,418 |
| Capital Expenditure | N/A | N/A | N/A | -16 | -16 |
| Free Cash Flow | -3,878 | -3,621 | -1,588 | -9,643 | -7,434 |